nifedipine has been researched along with exenatide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jiang, R; Li, Y; Wang, L; Wang, X; Yu, Q; Yuan, Y | 1 |
1 review(s) available for nifedipine and exenatide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for nifedipine and exenatide
| Article | Year |
|---|---|
Exendin-4 antagonizes Aβ1-42-induced suppression of long-term potentiation by regulating intracellular calcium homeostasis in rat hippocampal neurons.
Topics: Amyloid beta-Peptides; Animals; Calcium; Calcium Channel Blockers; Cells, Cultured; Electric Stimulation; Excitatory Amino Acid Antagonists; Exenatide; Hippocampus; Homeostasis; Hypoglycemic Agents; Long-Term Potentiation; Microscopy, Confocal; Neurons; Nifedipine; Patch-Clamp Techniques; Peptide Fragments; Peptides; Rats; Rats, Sprague-Dawley; Time Factors; Valine; Venoms | 2015 |